on Curatis Holding AG (isin : CH1330780979)
Curatis Establishes Expert Advisory Board to Guide Healthcare Innovations
Curatis Holding AG has announced the formation of an Advisory Board composed of four globally recognized experts in medical and scientific fields. This board includes leaders in pediatric oncology, neurology, drug development, and biochemistry, to steer Curatis's research initiatives and strategic plans.
CEO Roland Rutschmann expressed enthusiasm for welcoming these experts, emphasizing the board's importance in accelerating innovation to tackle critical healthcare challenges. Stewart Goldman, Prof. Dr. Andreas Gantenbein, Dr. Anthony Man, and Prof. Dr. Arnim Pause will provide invaluable guidance.
This development marks a pivotal point in Curatis's aim to become a leading provider of specialized medicines in Europe, enhancing healthcare innovation and patient outcomes. This strategic decision underscores Curatis's dedication to advancing medical science.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Curatis Holding AG news